FDA Inspection 1194075 — LifeSan Clinical Research
The FDA completed an inspection of LifeSan Clinical Research on December 9, 2022 in Mumbai. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- December 9, 2022
- Fiscal Year
- 2023
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Mumbai (India)
Additional Details
Clinical BA/BE